(Q38070173)

28 August 2017

1 reference

title

Rationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPD. (English)

1 reference

28 August 2017

1 reference

François Maltais

1

1 reference

28 August 2017

Natalie Dennis

series ordinal

2

1 reference

28 August 2017

Charles K N Chan

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

28 December 2012

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

79-103

1 reference

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Physical inactivity in patients with COPD, a controlled multi-center pilot-study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Long-term outcomes in mild/moderate chronic obstructive pulmonary disease in the European community respiratory health survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Does mild COPD affect prognosis in the elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Treatment of COPD: the sooner the better?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Earlier diagnosis and earlier treatment of COPD in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Smoking and lung function of Lung Health Study participants after 11 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Effects of smoking and smoking cessation on longitudinal decline in pulmonary function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Effect of ramelteon, a selective MT(1)/MT (2)-receptor agonist, on respiration during sleep in mild to moderate COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Anti-inflammatory effects and clinical efficacy of theophylline and tulobuterol in mild-to-moderate chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight training

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Peak inspiratory flow through the Genuair inhaler in patients with moderate or severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Do GOLD stages of COPD severity really correspond to differences in health status?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

C-reactive protein levels and survival in patients with moderate to very severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Six-minute walking and pulmonary function test outcomes during the early period after lung cancer surgery with special reference to patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Oxygen-enhanced magnetic resonance imaging versus computed tomography: multicenter study for clinical stage classification of smoking-related chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Properties of the COPD assessment test in a cross-sectional European study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Differences in cardiopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

The cost effectiveness of early treatment with fluticasone propionate 250 microg twice a day in subjects with obstructive airway disease. Results of the DIMCA program.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Delaying decline in pulmonary function with physical activity: a 25-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

COPD Stage and Risk of Hospitalization for Infectious Disease*

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Cardiovascular Morbidity in COPD: A Study of the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15412555.2012.719048

10.3109/15412555.2012.719048

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference